Global Cancer Drug Therapy Market Research Report 2020

Published Date : 2020-03-24

Category : Pharma & Healthcare

No. of Pages : 116


The global Cancer Drug Therapy market is valued at US$ xx million in 2020 is expected to reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2021-2026.
This report focuses on Cancer Drug Therapy volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Cancer Drug Therapy market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.
Market Segment Analysis
The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type, the Cancer Drug Therapy market is segmented into
Targeted Therapy
Chemotherapy
Immunotherapy

Segment by Application
Angiogenesis Inhibitors
mTOR Inhibitors
Monoclonal Antibodies
Cytokine Immunotherapy (IL-2)

Global Cancer Drug Therapy Market: Regional Analysis
The Cancer Drug Therapy market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Cancer Drug Therapy market report are:
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Global Cancer Drug Therapy Market: Competitive Analysis
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global Cancer Drug Therapy market include:
Amgen / Allergan
Argos Therapeutics
AstraZeneca
Aveo Pharmaceuticals
Bayer
Exelixis
Incyte
Merck
Roche
Bristol-Myers Squibb
Eisai
Exelixis
Genentech (Roche)
Novartis
Pfizer
Prometheus Labs

Table of Contents

1 Cancer Drug Therapy Market Overview
1.1 Product Overview and Scope of Cancer Drug Therapy
1.2 Cancer Drug Therapy Segment by Type
1.2.1 Global Cancer Drug Therapy Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Targeted Therapy
1.2.3 Chemotherapy
1.2.4 Immunotherapy
1.3 Cancer Drug Therapy Segment by Application
1.3.1 Cancer Drug Therapy Sales Comparison by Application: 2020 VS 2026
1.3.2 Angiogenesis Inhibitors
1.3.3 mTOR Inhibitors
1.3.4 Monoclonal Antibodies
1.3.5 Cytokine Immunotherapy (IL-2)
1.4 Global Cancer Drug Therapy Market Size Estimates and Forecasts
1.4.1 Global Cancer Drug Therapy Revenue 2015-2026
1.4.2 Global Cancer Drug Therapy Sales 2015-2026
1.4.3 Cancer Drug Therapy Market Size by Region: 2020 Versus 2026

2 Global Cancer Drug Therapy Market Competition by Manufacturers
2.1 Global Cancer Drug Therapy Sales Market Share by Manufacturers (2015-2020)
2.2 Global Cancer Drug Therapy Revenue Share by Manufacturers (2015-2020)
2.3 Global Cancer Drug Therapy Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Cancer Drug Therapy Manufacturing Sites, Area Served, Product Type
2.5 Cancer Drug Therapy Market Competitive Situation and Trends
2.5.1 Cancer Drug Therapy Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Cancer Drug Therapy Players (Opinion Leaders)

3 Cancer Drug Therapy Retrospective Market Scenario by Region
3.1 Global Cancer Drug Therapy Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Cancer Drug Therapy Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Cancer Drug Therapy Market Facts & Figures by Country
3.3.1 North America Cancer Drug Therapy Sales by Country
3.3.2 North America Cancer Drug Therapy Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Cancer Drug Therapy Market Facts & Figures by Country
3.4.1 Europe Cancer Drug Therapy Sales by Country
3.4.2 Europe Cancer Drug Therapy Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Cancer Drug Therapy Market Facts & Figures by Region
3.5.1 Asia Pacific Cancer Drug Therapy Sales by Region
3.5.2 Asia Pacific Cancer Drug Therapy Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Cancer Drug Therapy Market Facts & Figures by Country
3.6.1 Latin America Cancer Drug Therapy Sales by Country
3.6.2 Latin America Cancer Drug Therapy Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Cancer Drug Therapy Market Facts & Figures by Country
3.7.1 Middle East and Africa Cancer Drug Therapy Sales by Country
3.7.2 Middle East and Africa Cancer Drug Therapy Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Cancer Drug Therapy Historic Market Analysis by Type
4.1 Global Cancer Drug Therapy Sales Market Share by Type (2015-2020)
4.2 Global Cancer Drug Therapy Revenue Market Share by Type (2015-2020)
4.3 Global Cancer Drug Therapy Price Market Share by Type (2015-2020)
4.4 Global Cancer Drug Therapy Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Cancer Drug Therapy Historic Market Analysis by Application
5.1 Global Cancer Drug Therapy Sales Market Share by Application (2015-2020)
5.2 Global Cancer Drug Therapy Revenue Market Share by Application (2015-2020)
5.3 Global Cancer Drug Therapy Price by Application (2015-2020)

6 Company Profiles and Key Figures in Cancer Drug Therapy Business
6.1 Amgen / Allergan
6.1.1 Corporation Information
6.1.2 Amgen / Allergan Description, Business Overview and Total Revenue
6.1.3 Amgen / Allergan Cancer Drug Therapy Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Amgen / Allergan Products Offered
6.1.5 Amgen / Allergan Recent Development
6.2 Argos Therapeutics
6.2.1 Argos Therapeutics Cancer Drug Therapy Production Sites and Area Served
6.2.2 Argos Therapeutics Description, Business Overview and Total Revenue
6.2.3 Argos Therapeutics Cancer Drug Therapy Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Argos Therapeutics Products Offered
6.2.5 Argos Therapeutics Recent Development
6.3 AstraZeneca
6.3.1 AstraZeneca Cancer Drug Therapy Production Sites and Area Served
6.3.2 AstraZeneca Description, Business Overview and Total Revenue
6.3.3 AstraZeneca Cancer Drug Therapy Sales, Revenue and Gross Margin (2015-2020)
6.3.4 AstraZeneca Products Offered
6.3.5 AstraZeneca Recent Development
6.4 Aveo Pharmaceuticals
6.4.1 Aveo Pharmaceuticals Cancer Drug Therapy Production Sites and Area Served
6.4.2 Aveo Pharmaceuticals Description, Business Overview and Total Revenue
6.4.3 Aveo Pharmaceuticals Cancer Drug Therapy Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Aveo Pharmaceuticals Products Offered
6.4.5 Aveo Pharmaceuticals Recent Development
6.5 Bayer
6.5.1 Bayer Cancer Drug Therapy Production Sites and Area Served
6.5.2 Bayer Description, Business Overview and Total Revenue
6.5.3 Bayer Cancer Drug Therapy Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Bayer Products Offered
6.5.5 Bayer Recent Development
6.6 Exelixis
6.6.1 Exelixis Cancer Drug Therapy Production Sites and Area Served
6.6.2 Exelixis Description, Business Overview and Total Revenue
6.6.3 Exelixis Cancer Drug Therapy Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Exelixis Products Offered
6.6.5 Exelixis Recent Development
6.7 Incyte
6.6.1 Incyte Cancer Drug Therapy Production Sites and Area Served
6.6.2 Incyte Description, Business Overview and Total Revenue
6.6.3 Incyte Cancer Drug Therapy Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Incyte Products Offered
6.7.5 Incyte Recent Development
6.8 Merck
6.8.1 Merck Cancer Drug Therapy Production Sites and Area Served
6.8.2 Merck Description, Business Overview and Total Revenue
6.8.3 Merck Cancer Drug Therapy Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Merck Products Offered
6.8.5 Merck Recent Development
6.9 Roche
6.9.1 Roche Cancer Drug Therapy Production Sites and Area Served
6.9.2 Roche Description, Business Overview and Total Revenue
6.9.3 Roche Cancer Drug Therapy Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Roche Products Offered
6.9.5 Roche Recent Development
6.10 Bristol-Myers Squibb
6.10.1 Bristol-Myers Squibb Cancer Drug Therapy Production Sites and Area Served
6.10.2 Bristol-Myers Squibb Description, Business Overview and Total Revenue
6.10.3 Bristol-Myers Squibb Cancer Drug Therapy Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Bristol-Myers Squibb Products Offered
6.10.5 Bristol-Myers Squibb Recent Development
6.11 Eisai
6.11.1 Eisai Cancer Drug Therapy Production Sites and Area Served
6.11.2 Eisai Cancer Drug Therapy Description, Business Overview and Total Revenue
6.11.3 Eisai Cancer Drug Therapy Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Eisai Products Offered
6.11.5 Eisai Recent Development
6.12 Exelixis
6.12.1 Exelixis Cancer Drug Therapy Production Sites and Area Served
6.12.2 Exelixis Cancer Drug Therapy Description, Business Overview and Total Revenue
6.12.3 Exelixis Cancer Drug Therapy Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Exelixis Products Offered
6.12.5 Exelixis Recent Development
6.13 Genentech (Roche)
6.13.1 Genentech (Roche) Cancer Drug Therapy Production Sites and Area Served
6.13.2 Genentech (Roche) Cancer Drug Therapy Description, Business Overview and Total Revenue
6.13.3 Genentech (Roche) Cancer Drug Therapy Sales, Revenue and Gross Margin (2015-2020)
6.13.4 Genentech (Roche) Products Offered
6.13.5 Genentech (Roche) Recent Development
6.14 Novartis
6.14.1 Novartis Cancer Drug Therapy Production Sites and Area Served
6.14.2 Novartis Cancer Drug Therapy Description, Business Overview and Total Revenue
6.14.3 Novartis Cancer Drug Therapy Sales, Revenue and Gross Margin (2015-2020)
6.14.4 Novartis Products Offered
6.14.5 Novartis Recent Development
6.15 Pfizer
6.15.1 Pfizer Cancer Drug Therapy Production Sites and Area Served
6.15.2 Pfizer Cancer Drug Therapy Description, Business Overview and Total Revenue
6.15.3 Pfizer Cancer Drug Therapy Sales, Revenue and Gross Margin (2015-2020)
6.15.4 Pfizer Products Offered
6.15.5 Pfizer Recent Development
6.16 Prometheus Labs
6.16.1 Prometheus Labs Cancer Drug Therapy Production Sites and Area Served
6.16.2 Prometheus Labs Cancer Drug Therapy Description, Business Overview and Total Revenue
6.16.3 Prometheus Labs Cancer Drug Therapy Sales, Revenue and Gross Margin (2015-2020)
6.16.4 Prometheus Labs Products Offered
6.16.5 Prometheus Labs Recent Development

7 Cancer Drug Therapy Manufacturing Cost Analysis
7.1 Cancer Drug Therapy Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Cancer Drug Therapy
7.4 Cancer Drug Therapy Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Cancer Drug Therapy Distributors List
8.3 Cancer Drug Therapy Customers

9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis

10 Global Market Forecast
10.1 Global Cancer Drug Therapy Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Cancer Drug Therapy by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Cancer Drug Therapy by Type (2021-2026)
10.2 Cancer Drug Therapy Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Cancer Drug Therapy by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Cancer Drug Therapy by Application (2021-2026)
10.3 Cancer Drug Therapy Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Cancer Drug Therapy by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Cancer Drug Therapy by Region (2021-2026)
10.4 North America Cancer Drug Therapy Estimates and Projections (2021-2026)
10.5 Europe Cancer Drug Therapy Estimates and Projections (2021-2026)
10.6 Asia Pacific Cancer Drug Therapy Estimates and Projections (2021-2026)
10.7 Latin America Cancer Drug Therapy Estimates and Projections (2021-2026)
10.8 Middle East and Africa Cancer Drug Therapy Estimates and Projections (2021-2026)
11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer


List of Tables
Table 1. Global Cancer Drug Therapy Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Cancer Drug Therapy Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Cancer Drug Therapy Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. Global Key Cancer Drug Therapy Manufacturers Covered in This Study
Table 5. Global Cancer Drug Therapy Sales (K Units) by Manufacturers (2015-2020)
Table 6. Global Cancer Drug Therapy Sales Share by Manufacturers (2015-2020)
Table 7. Global Cancer Drug Therapy Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Cancer Drug Therapy Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Cancer Drug Therapy Average Price (USD/Unit) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Cancer Drug Therapy Sales Sites and Area Served
Table 11. Manufacturers Cancer Drug Therapy Product Types
Table 12. Global Cancer Drug Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Cancer Drug Therapy by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Drug Therapy as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Cancer Drug Therapy Players
Table 16. Global Cancer Drug Therapy Sales (K Units) by Region (2015-2020)
Table 17. Global Cancer Drug Therapy Sales Market Share by Region (2015-2020)
Table 18. Global Cancer Drug Therapy Revenue (Million US$) by Region (2015-2020)
Table 19. Global Cancer Drug Therapy Revenue Market Share by Region (2015-2020)
Table 20. North America Cancer Drug Therapy Sales by Country (2015-2020) (K Units)
Table 21. North America Cancer Drug Therapy Sales Market Share by Country (2015-2020)
Table 22. North America Cancer Drug Therapy Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Cancer Drug Therapy Revenue Market Share by Country (2015-2020)
Table 24. Europe Cancer Drug Therapy Sales by Country (2015-2020) (K Units)
Table 25. Europe Cancer Drug Therapy Sales Market Share by Country (2015-2020)
Table 26. Europe Cancer Drug Therapy Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Cancer Drug Therapy Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Cancer Drug Therapy Sales by Region (2015-2020) (K Units)
Table 29. Asia Pacific Cancer Drug Therapy Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Cancer Drug Therapy Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Cancer Drug Therapy Revenue Market Share by Region (2015-2020)
Table 32. Latin America Cancer Drug Therapy Sales by Country (2015-2020) (K Units)
Table 33. Latin America Cancer Drug Therapy Sales Market Share by Country (2015-2020)
Table 34. Latin America Cancer Drug Therapy Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Cancer Drug Therapy Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Cancer Drug Therapy Sales by Country (2015-2020) (K Units)
Table 37. Middle East and Africa Cancer Drug Therapy Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Cancer Drug Therapy Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Cancer Drug Therapy Revenue Market Share by Country (2015-2020)
Table 40. Global Cancer Drug Therapy Sales (K Units) by Type (2015-2020)
Table 41. Global Cancer Drug Therapy Sales Share by Type (2015-2020)
Table 42. Global Cancer Drug Therapy Revenue (Million US$) by Type (2015-2020)
Table 43. Global Cancer Drug Therapy Revenue Share by Type (2015-2020)
Table 44. Global Cancer Drug Therapy Price (USD/Unit) by Type (2015-2020)
Table 45. Global Cancer Drug Therapy Sales (K Units) by Application (2015-2020)
Table 46. Global Cancer Drug Therapy Sales Market Share by Application (2015-2020)
Table 47. Global Cancer Drug Therapy Sales Growth Rate by Application (2015-2020)
Table 48. Amgen / Allergan Cancer Drug Therapy Corporation Information
Table 49. Amgen / Allergan Description and Business Overview
Table 50. Amgen / Allergan Cancer Drug Therapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 51. Amgen / Allergan Main Product
Table 52. Amgen / Allergan Recent Development
Table 53. Argos Therapeutics Cancer Drug Therapy Corporation Information
Table 54. Argos Therapeutics Corporation Information
Table 55. Argos Therapeutics Cancer Drug Therapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 56. Argos Therapeutics Main Product
Table 57. Argos Therapeutics Recent Development
Table 58. AstraZeneca Cancer Drug Therapy Corporation Information
Table 59. AstraZeneca Corporation Information
Table 60. AstraZeneca Cancer Drug Therapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 61. AstraZeneca Main Product
Table 62. AstraZeneca Recent Development
Table 63. Aveo Pharmaceuticals Cancer Drug Therapy Corporation Information
Table 64. Aveo Pharmaceuticals Corporation Information
Table 65. Aveo Pharmaceuticals Cancer Drug Therapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 66. Aveo Pharmaceuticals Main Product
Table 67. Aveo Pharmaceuticals Recent Development
Table 68. Bayer Cancer Drug Therapy Corporation Information
Table 69. Bayer Corporation Information
Table 70. Bayer Cancer Drug Therapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 71. Bayer Main Product
Table 72. Bayer Recent Development
Table 73. Exelixis Cancer Drug Therapy Corporation Information
Table 74. Exelixis Corporation Information
Table 75. Exelixis Cancer Drug Therapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 76. Exelixis Main Product
Table 77. Exelixis Recent Development
Table 78. Incyte Cancer Drug Therapy Corporation Information
Table 79. Incyte Corporation Information
Table 80. Incyte Cancer Drug Therapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. Incyte Main Product
Table 82. Incyte Recent Development
Table 83. Merck Cancer Drug Therapy Corporation Information
Table 84. Merck Corporation Information
Table 85. Merck Cancer Drug Therapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. Merck Main Product
Table 87. Merck Recent Development
Table 88. Roche Cancer Drug Therapy Corporation Information
Table 89. Roche Corporation Information
Table 90. Roche Cancer Drug Therapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 91. Roche Main Product
Table 92. Roche Recent Development
Table 93. Bristol-Myers Squibb Cancer Drug Therapy Corporation Information
Table 94. Bristol-Myers Squibb Corporation Information
Table 95. Bristol-Myers Squibb Cancer Drug Therapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 96. Bristol-Myers Squibb Main Product
Table 97. Bristol-Myers Squibb Recent Development
Table 98. Eisai Cancer Drug Therapy Corporation Information
Table 99. Eisai Corporation Information
Table 100. Eisai Cancer Drug Therapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 101. Eisai Main Product
Table 102. Eisai Recent Development
Table 103. Exelixis Cancer Drug Therapy Corporation Information
Table 104. Exelixis Corporation Information
Table 105. Exelixis Cancer Drug Therapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 106. Exelixis Main Product
Table 107. Exelixis Recent Development
Table 108. Genentech (Roche) Cancer Drug Therapy Corporation Information
Table 109. Genentech (Roche) Corporation Information
Table 110. Genentech (Roche) Cancer Drug Therapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 111. Genentech (Roche) Main Product
Table 112. Genentech (Roche) Recent Development
Table 113. Novartis Cancer Drug Therapy Corporation Information
Table 114. Novartis Corporation Information
Table 115. Novartis Cancer Drug Therapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 116. Novartis Main Product
Table 117. Novartis Recent Development
Table 118. Pfizer Cancer Drug Therapy Corporation Information
Table 119. Pfizer Corporation Information
Table 120. Pfizer Cancer Drug Therapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 121. Pfizer Main Product
Table 122. Pfizer Recent Development
Table 123. Prometheus Labs Cancer Drug Therapy Corporation Information
Table 124. Prometheus Labs Corporation Information
Table 125. Prometheus Labs Cancer Drug Therapy Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 126. Prometheus Labs Main Product
Table 127. Prometheus Labs Recent Development
Table 128. Sales Base and Market Concentration Rate of Raw Material
Table 129. Key Suppliers of Raw Materials
Table 130. Cancer Drug Therapy Distributors List
Table 131. Cancer Drug Therapy Customers List
Table 132. Market Key Trends
Table 133. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 134. Key Challenges
Table 135. Global Cancer Drug Therapy Sales (K Units) Forecast by Type (2021-2026)
Table 136. Global Cancer Drug Therapy Sales Market Share Forecast by Type (2021-2026)
Table 137. Global Cancer Drug Therapy Revenue (Million US$) Forecast by Type (2021-2026)
Table 138. Global Cancer Drug Therapy Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 139. Global Cancer Drug Therapy Sales (K Units) Forecast by Application (2021-2026)
Table 140. Global Cancer Drug Therapy Revenue (Million US$) Forecast by Application (2021-2026)
Table 141. Global Cancer Drug Therapy Sales (K Units) Forecast by Region (2021-2026)
Table 142. Global Cancer Drug Therapy Sales Market Share Forecast by Region (2021-2026)
Table 143. Global Cancer Drug Therapy Revenue Forecast by Region (2021-2026) (US$ Million)
Table 144. Global Cancer Drug Therapy Revenue Market Share Forecast by Region (2021-2026)
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Cancer Drug Therapy
Figure 2. Global Cancer Drug Therapy Sales Market Share by Type: 2020 VS 2026
Figure 3. Targeted Therapy Product Picture
Figure 4. Chemotherapy Product Picture
Figure 5. Immunotherapy Product Picture
Figure 6. Global Cancer Drug Therapy Consumption Market Share by Application: 2020 VS 2026
Figure 7. Angiogenesis Inhibitors
Figure 8. mTOR Inhibitors
Figure 9. Monoclonal Antibodies
Figure 10. Cytokine Immunotherapy (IL-2)
Figure 11. Global Cancer Drug Therapy Market Size 2015-2026 (US$ Million)
Figure 12. Global Cancer Drug Therapy Sales Capacity (K Units) (2015-2026)
Figure 13. Global Cancer Drug Therapy Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Cancer Drug Therapy Sales Share by Manufacturers in 2020
Figure 15. Global Cancer Drug Therapy Revenue Share by Manufacturers in 2019
Figure 16. The Global 5 and 10 Largest Players: Market Share by Cancer Drug Therapy Revenue in 2019
Figure 17. Cancer Drug Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 18. Global Cancer Drug Therapy Sales Market Share by Region (2015-2020)
Figure 19. Global Cancer Drug Therapy Sales Market Share by Region in 2019
Figure 20. Global Cancer Drug Therapy Revenue Market Share by Region (2015-2020)
Figure 21. Global Cancer Drug Therapy Revenue Market Share by Region in 2019
Figure 22. North America Cancer Drug Therapy Sales Market Share by Country in 2019
Figure 23. North America Cancer Drug Therapy Revenue Market Share by Country in 2019
Figure 24. U.S. Cancer Drug Therapy Sales Growth Rate (2015-2020) (K Units)
Figure 25. U.S. Cancer Drug Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Canada Cancer Drug Therapy Sales Growth Rate (2015-2020) (K Units)
Figure 27. Canada Cancer Drug Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 28. Europe Cancer Drug Therapy Sales Market Share by Country in 2019
Figure 29. Europe Cancer Drug Therapy Revenue Market Share by Country in 2019
Figure 30. Germany Cancer Drug Therapy Sales Growth Rate (2015-2020) (K Units)
Figure 31. Germany Cancer Drug Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. France Cancer Drug Therapy Sales Growth Rate (2015-2020) (K Units)
Figure 33. France Cancer Drug Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. U.K. Cancer Drug Therapy Sales Growth Rate (2015-2020) (K Units)
Figure 35. U.K. Cancer Drug Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Italy Cancer Drug Therapy Sales Growth Rate (2015-2020) (K Units)
Figure 37. Italy Cancer Drug Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Russia Cancer Drug Therapy Sales Growth Rate (2015-2020) (K Units)
Figure 39. Russia Cancer Drug Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Asia Pacific Cancer Drug Therapy Sales Market Share by Region in 2019
Figure 41. Asia Pacific Cancer Drug Therapy Revenue Market Share by Region in 2019
Figure 42. China Cancer Drug Therapy Sales Growth Rate (2015-2020) (K Units)
Figure 43. China Cancer Drug Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. Japan Cancer Drug Therapy Sales Growth Rate (2015-2020) (K Units)
Figure 45. Japan Cancer Drug Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. South Korea Cancer Drug Therapy Sales Growth Rate (2015-2020) (K Units)
Figure 47. South Korea Cancer Drug Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. India Cancer Drug Therapy Sales Growth Rate (2015-2020) (K Units)
Figure 49. India Cancer Drug Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Australia Cancer Drug Therapy Sales Growth Rate (2015-2020) (K Units)
Figure 51. Australia Cancer Drug Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Taiwan Cancer Drug Therapy Sales Growth Rate (2015-2020) (K Units)
Figure 53. Taiwan Cancer Drug Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Indonesia Cancer Drug Therapy Sales Growth Rate (2015-2020) (K Units)
Figure 55. Indonesia Cancer Drug Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Thailand Cancer Drug Therapy Sales Growth Rate (2015-2020) (K Units)
Figure 57. Thailand Cancer Drug Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Malaysia Cancer Drug Therapy Sales Growth Rate (2015-2020) (K Units)
Figure 59. Malaysia Cancer Drug Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Philippines Cancer Drug Therapy Sales Growth Rate (2015-2020) (K Units)
Figure 61. Philippines Cancer Drug Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Vietnam Cancer Drug Therapy Sales Growth Rate (2015-2020) (K Units)
Figure 63. Vietnam Cancer Drug Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Latin America Cancer Drug Therapy Sales Market Share by Country in 2019
Figure 65. Latin America Cancer Drug Therapy Revenue Market Share by Country in 2019
Figure 66. Mexico Cancer Drug Therapy Sales Growth Rate (2015-2020) (K Units)
Figure 67. Mexico Cancer Drug Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Brazil Cancer Drug Therapy Sales Growth Rate (2015-2020) (K Units)
Figure 69. Brazil Cancer Drug Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Argentina Cancer Drug Therapy Sales Growth Rate (2015-2020) (K Units)
Figure 71. Argentina Cancer Drug Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Middle East and Africa Cancer Drug Therapy Sales Market Share by Country in 2019
Figure 73. Middle East and Africa Cancer Drug Therapy Revenue Market Share by Country in 2019
Figure 74. Turkey Cancer Drug Therapy Sales Growth Rate (2015-2020) (K Units)
Figure 75. Turkey Cancer Drug Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Saudi Arabia Cancer Drug Therapy Sales Growth Rate (2015-2020) (K Units)
Figure 77. Saudi Arabia Cancer Drug Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. U.A.E Cancer Drug Therapy Sales Growth Rate (2015-2020) (K Units)
Figure 79. U.A.E Cancer Drug Therapy Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Sales Market Share of Cancer Drug Therapy by Type (2015-2020)
Figure 81. Sales Market Share of Cancer Drug Therapy by Type in 2019
Figure 82. Revenue Share of Cancer Drug Therapy by Type (2015-2020)
Figure 83. Revenue Market Share of Cancer Drug Therapy by Type in 2019
Figure 84. Global Cancer Drug Therapy Sales Growth by Type (2015-2020) (K Units)
Figure 85. Global Cancer Drug Therapy Sales Market Share by Application (2015-2020)
Figure 86. Global Cancer Drug Therapy Sales Market Share by Application in 2019
Figure 87. Global Revenue Share of Cancer Drug Therapy by Application (2015-2020)
Figure 88. Global Revenue Share of Cancer Drug Therapy by Application in 2020
Figure 89. Amgen / Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Argos Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Aveo Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Exelixis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Incyte Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Eisai Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. Exelixis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 101. Genentech (Roche) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 102. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 103. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 104. Prometheus Labs Total Revenue (US$ Million): 2019 Compared with 2018
Figure 105. Price Trend of Key Raw Materials
Figure 106. Manufacturing Cost Structure of Cancer Drug Therapy
Figure 107. Manufacturing Process Analysis of Cancer Drug Therapy
Figure 108. Cancer Drug Therapy Industrial Chain Analysis
Figure 109. Channels of Distribution
Figure 110. Distributors Profiles
Figure 111. Porter's Five Forces Analysis
Figure 112. North America Cancer Drug Therapy Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 113. North America Cancer Drug Therapy Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 114. Europe Cancer Drug Therapy Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 115. Europe Cancer Drug Therapy Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 116. Latin America Cancer Drug Therapy Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 117. Latin America Cancer Drug Therapy Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 118. Middle East and Africa Cancer Drug Therapy Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 119. Middle East and Africa Cancer Drug Therapy Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 120. Asia Pacific Cancer Drug Therapy Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 121. Asia Pacific Cancer Drug Therapy Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed

Cancer Drug Therapy  Research Assistance Research Assistance

We will be happy to help you find what you need. Please write to us:

+1-888-213-4282

sales@researchreportcenter.com